Letrozole is a non-steroidal aromatase inhibitor. Aromatase converts androgens to estrogens, so inhibition reduces estrogen synthesis—an important strategy in hormone-sensitive breast cancer. Tamoxifen is not an aromatase inhibitor. It is a selective estrogen receptor modulator that acts primarily by blocking estrogen receptors in breast tissue.
